RC
Insider
R Michael Carruthers
Chief Financial OfficerR Michael Carruthers (Chief Financial Officer) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Edgewise Therapeutics, Inc. (EWTX).
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
–
no filings in the window
Last traded
Sep 20 2024
Filed Sep 24 2024
Median ADV $64.2M across their filed names
Open performance→Most traded names
EWTXRecent filings
EWTXSALE
Edgewise Therapeutics, Inc.
View filing →
$3.6M125,092 sh across 4 lots
Exec Sep 20 2024
Filed Sep 24 2024 · 5:30 PM ET